111 Inc. - ADR

$4.25

up-down-arrow $-0.15 (-3.41%)

As on 10-Jun-2026 10:37EDT

Market cap

info icon

$42 Mln

Revenue (TTM)

info icon

$11,349 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

17.7

Div. Yield

info icon

0 %

111 - ADR Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 4.05 High: 4.55

52 Week Range

Low: 2.48 High: 11.17

Liquidityliquidity Moderate

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -0.1 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    31.22

  • EV/EBITDAEV/EBITDA information

    0.1

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $--

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    5,196,964

8 Years Aggregate

CFO

CN¥-2,675.34 Mln

EBITDA

CN¥-3,204.53 Mln

Net Profit

CN¥-3,406.95 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
111 - ADR
66.0 -29.8 -38.8 -49.0 -46.6 -46.0 --
BSE Sensex
-12.6 -4.3 -4.6 -10.3 5.7 7.3 10.7
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 10-Jun-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2022
2021
2020
2019
111 - ADR
-58.9 -59.5 -48.7 -13.7 -49.6 3.3 9.6
S&P Small-Cap 600
4.0 7.0 13.9 -17.4 25.3 9.6 20.9
BSE Sensex
9.1 8.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (CN¥ Mln)

loading...

*All values are in (CN¥ Mln)

loading...

*All values are in (CN¥ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
111 - ADR
4.3 42.1 11,349.4 -75.4 0.0 -- -- 17.7
2.3 448.8 3,151.4 -269.9 -5.3 93.4 -- 6.4

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About 111 - ADR

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration...  services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services. It also provides 1 Pharmacy online wholesale pharmacy that offers pharmaceutical and other health and wellness products; and 1 Medicine Marketplace online retail pharmacy that provides drugs, nutritional supplements, medical supplies and devices, personal care, and baby products. In addition, the company offers online loan application services; cloud-based inventory management services; smart procurement services, which collect pharmacies' historical purchase orders and inventory data; and Hawkeye automated salesforce tool, as well as online consultation, e-prescription, and data services. Further, its pharmacies provide drugs, including prescription and over-the-counter drugs comprising Western and Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices that consists of bandages and thermometers; and personal care products that include skin care, birth control, sexual wellness, and baby products. Additionally, the company offers research and development, and consulting services; warehousing, procurement, and logistics services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies, medical professionals, and marketplace sellers. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China. 

  • Co-Founder & Executive Chairman

    Dr. Gang Yu

  • Co-Founder & Executive Chairman

    Dr. Gang Yu Ph.D.

  • Headquarters

    Shanghai

  • Website

    https://corporate.111.com.cn

Edit peer-selector-edit
loading...
loading...

FAQs for 111 - ADR

The share price of 111 Inc - ADR is $4.25 (NASDAQ) as of 10-Jun-2026 10:37 EDT. 111 Inc - ADR has given a return of -46.59% in the last 3 years.

Since, TTM earnings of 111 Inc - ADR is negative, P/E ratio is not available.
The P/B ratio of 111 Inc - ADR is 17.66 times as on 05-Jun-2026, a 158 premium to its peers’ median range of 6.85 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
-1.37
-0.03
2024
-0.09
-0.01
2023
-0.03
-0.02
2022
-0.06
-0.06
2021
-0.04
-0.16

The 52-week high and low of 111 Inc - ADR are Rs 11.17 and Rs 2.48 as of 10-Jun-2026.

111 Inc - ADR has a market capitalisation of $ 42 Mln as on 05-Jun-2026. As per SEBI classification, it is a Small Cap company.

Before investing in 111 Inc - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.